Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Dec 7:11:91.
doi: 10.3389/fnsys.2017.00091. eCollection 2017.

Commentary: Localized vs. Systematic Neurodegeneration: A Paradigm Shift in Understanding Neurodegenerative Diseases

Bianca Norrara  1 , Jhulimar G Doerl  1 , Fausto P Guzen  1 , Jose Rodolfo Lopes P Cavalcanti  1 , Marco Aurelio M Freire  1
Affiliations
Comment

Commentary: Localized vs. Systematic Neurodegeneration: A Paradigm Shift in Understanding Neurodegenerative Diseases

Bianca Norrara et al. Front Syst Neurosci. .
No abstract available

Keywords: excitotoxicity; inflammation; nervous system; neurodegeneration; therapeutics.

PubMed Disclaimer

Comment on

References

    1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., et al. (2000). Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383–421. - PMC - PubMed
    1. Allan S. M., Rothwell N. J. (2001). Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734–744. 10.1038/35094583 - DOI - PubMed
    1. Ambrosi G., Cerri S., Blandini F. (2014). A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease. J. Neural Transm. 121, 849–859. 10.1007/s00702-013-1149-z - DOI - PubMed
    1. Amor S., Peferoen L. A., Vogel D. Y., Breur M., van der Valk P., Baker D., et al. (2014). Inflammation in neurodegenerative diseases–an update. Immunology 142, 151–166. 10.1111/imm.12233 - DOI - PMC - PubMed
    1. Araujo R. F., Jr., Reinaldo M. P. O., Brito G. A., Cavalcanti P. F., Freire M. A. M., Medeiros C. A., et al. (2014). Olmesartan decreased levels of IL-1β and TNF-α, down-regulMMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis model. PLoS ONE 9:e114923. 10.1371/journal.pone.0114923 - DOI - PMC - PubMed

LinkOut - more resources